BA
VCEL icon

Boston Advisors’s Vericel Corp VCEL Stock Holding History

Boston Advisors’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.05M Buy
69,411
+22,571
+48% +$395K 0.05% 378
2019
Q2 		$885K Buy
46,840
+7,277
+18% +$124K 0.05% 387
2019
Q1 		$693K Sell
39,563
-85
-0.2% -$1.55K 0.04% 410
2018
Q4 		$690K Sell
39,648
-24,147
-38% -$361K 0.04% 404
2018
Q3 		$903K Buy
63,795
+33,230
+109% +$390K 0.04% 398
2018
Q2 		$296K Buy
+30,565
New +$381K 0.01% 579

Other funds holding VCEL

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Boston Advisors's VCEL Position: Q3 2019 in Review

Boston Advisors increased its Vericel Corp (VCEL) stake by 48% in Q3 2019, buying an estimated $395K and bringing the position to 69,411 shares worth $1.05M. The position accounts for 0.05% of the portfolio, ranked #378.

Boston Advisors first reported a position in VCEL in Q2 2018 and has held it in 6 quarters since. 137 funds tracked by Wall St. Rank hold VCEL as of Q3 2019.

  • Boston Advisors held 69,411 shares of Vericel Corp worth $1.05M as of Q3 2019.
  • Boston Advisors bought 22,571 Vericel Corp shares in Q3 2019, an estimated $395K.
  • Vericel Corp made up 0.05% of Boston Advisors's portfolio in Q3 2019, its #378 holding.
  • Boston Advisors first reported a position in Vericel Corp in Q2 2018 and has held it in 6 quarters since.
  • 137 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.